Sanathan Textile (SANATHAN)

Cyclical

FairStock Score: 30/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹471.35
Market Cap₹3,978.39 Cr
P/E Ratio65.37
ROCE10.39%
ROE13.53%
Dividend Yield0%
Profit Growth37.64%
Debt/Equity0.81
Sales Growth7.22%
Promoter Holding78.58%
52-Week Range₹352.6 — ₹551.95
SectorTextiles & Apparels
Book Value₹222.18

Strengths

Concerns

AI Analysis

When I examine Sanathan Textile, I try to apply the same tests I have used for decades. First, can I understand the business? Yes, it is a textile producer in a competitive industry. But do I see a moat? No. The numbers confirm my skepticism. Return on equity is 13.53%, and return on capital employed is just 10.39%. These are single-digit to low-double-digit returns, hardly compensation for the risk in a commodity business. The balance sheet shows debt-to-equity of 0.78, which is tolerable but not conservative. The latest quarter reports a net loss of ₹5 crore on sales of ₹1,079 crore, meaning margins have collapsed. Sales growth of 45.15% looks impressive at first, but profit growth of -113.96% shows that this growth is destroying earnings rather than building them. A Piotroski F-score of 4 out of 9 reinforces the weak fundamentals. At ₹439.35, the market values the company at ₹3,456 crore, or 34.75 times trailing earnings and 2.67 times book value. With book value of ₹164.60, you are paying a substantial premium for a business whose returns are mediocre and whose profits have turned negative. There is no dividend to compensate patient shareholders. Promoter holding at 78.58% is positive, as it aligns interests, but it does not make a bad business good. In Graham's words, the market is a voting machine; this looks like a speculative vote on a cyclical recovery. I prefer to invest when a business shows consistent profitability, not when I have to hope that a turnaround materializes. I would pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer